Tyrosine kinases as targets for cancer therapy
DS Krause, RA Van Etten - New England Journal of Medicine, 2005 - Mass Medical Soc
Tyrosine kinases, enzymes that catalyze the transfer of phosphate from ATP to tyrosine
residues in polypeptides, are ubiquitous, numerous, and of considerable clinical interest …
residues in polypeptides, are ubiquitous, numerous, and of considerable clinical interest …
Eosinophilic gastrointestinal disorders (EGID)
ME Rothenberg - Journal of Allergy and Clinical Immunology, 2004 - Elsevier
Primary eosinophilic gastrointestinal disorders are defined as disorders that selectively
affect the gastrointestinal tract with eosinophil-rich inflammation in the absence of known …
affect the gastrointestinal tract with eosinophil-rich inflammation in the absence of known …
Eosinophils: biological properties and role in health and disease
SP Hogan, HF Rosenberg, R Moqbel… - Clinical & …, 2008 - Wiley Online Library
Eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation
of diverse inflammatory responses, as well as modulators of innate and adaptive immunity …
of diverse inflammatory responses, as well as modulators of innate and adaptive immunity …
Targeting the PDGF signaling pathway in tumor treatment
CH Heldin - Cell Communication and Signaling, 2013 - Springer
Platelet-derived growth factor (PDGF) isoforms and PDGF receptors have important
functions in the regulation of growth and survival of certain cell types during embryonal …
functions in the regulation of growth and survival of certain cell types during embryonal …
Contributions of eosinophils to human health and disease
AD Klion, SJ Ackerman… - Annual Review of …, 2020 - annualreviews.org
The human eosinophil has long been thought to favorably influence innate mucosal
immunity but at times has also been incriminated in disease pathophysiology. Research into …
immunity but at times has also been incriminated in disease pathophysiology. Research into …
World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management
W Shomali, J Gotlib - American Journal of Hematology, 2019 - Wiley Online Library
Disease overview The eosinophilias encompass a broad range of non‐hematologic
(secondary or reactive) and hematologic (primary or clonal) disorders with potential for end …
(secondary or reactive) and hematologic (primary or clonal) disorders with potential for end …
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy
PU Ogbogu, BS Bochner, JH Butterfield… - Journal of Allergy and …, 2009 - Elsevier
BACKGROUND: Hypereosinophilic syndrome (HES) is a heterogeneous group of rare
disorders defined by persistent blood eosinophilia≥ 1.5× 109/L, absence of a secondary …
disorders defined by persistent blood eosinophilia≥ 1.5× 109/L, absence of a secondary …
Eosinophils and cancer
Eosinophils have long been known to infiltrate tumors, and in most cases, this is associated
with an improved prognosis. However, the reasons behind this infiltration and the …
with an improved prognosis. However, the reasons behind this infiltration and the …
Myeloid neoplasms with eosinophilia
A Reiter, J Gotlib - Blood, The Journal of the American Society …, 2017 - ashpublications.org
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of
myeloid neoplasms with eosinophilia. The family of diseases generated by dysregulated …
myeloid neoplasms with eosinophilia. The family of diseases generated by dysregulated …
Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
A Pardanani - American journal of hematology, 2019 - Wiley Online Library
Overview Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast
cells (MCs) in extra‐cutaneous organs. Diagnosis The major criterion is presence of …
cells (MCs) in extra‐cutaneous organs. Diagnosis The major criterion is presence of …